Pharm-Rx Irinotecan HCL
- CAS Number
- 136572-09-3
- Chemical Name
- Irinotecan Hydrochloride Hydrate
- Molecular Formula
- C₃₃H₃₈N₄O₆· HCl · 3H₂O
Product families
Applications
- Other Drug & Care Solutions
Product Families
- Active Pharmaceutical Ingredients (APIs)
Other characteristics
- Markets
- Healthcare & Pharma
- Definition
Irinotecan Hydrochloride contains NLT 98.0% and NMT 102.0% of C33H38N4O6 · HCl, calculated on the anhydrous basis.
- Technology
- Pharmaceuticals & Nutraceuticals
- FDA Disclaimer
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
- Storage Information
Preserve in tight, light-resistant containers, and store at controlled room temperature.
- USP Reference Standards
USP Irinotecan Hydrochloride RS USP Irinotecan Related Compound A RS (S)-4-Ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7] indolizino[1,2-b]quinoline-3,14(4H,12H)-dione. C20H16N2O5 364.35; USP Irinotecan Related Compound B RS (S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione. C22H20N2O5 392.40; USP Irinotecan Related Compound C RS 11-Ethyl-4-hydroxy-4-methyl-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-9-yl (1,4′-bipiperidine)-1′carboxylate hydrochloride. C32H36N4O6· HCl 609.11; USP Irinotecan Related Compound D RS (R)-9-[(1,4'-Bipiperidine)-1'-carbonyloxy]-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline hydrochloride, trihydrate. C33H38N4O6· HCl · 3 H2O 677.18
Technical data
Table 1 of 1
1 row| Characteristic | Value |
|---|---|
| Molecular Weight | 623.14 |
